Evidence map›Paper›PMID 36131769›Full record

ArticleNanoscale advances2022

Plasmon enhanced light-matter interaction of rice-like nanorods by a cube-plate nanocavity.

Hui Zhang, Huan Chen, Tingting Zhang, Xiaohu Mi, Zihe Jiang, Ziming Zhou, Lei Guo, Min Zhang, Zhenglong Zhang, Ning Liu and 1 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanoscale advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Hui ZhangDepartment of Physics and Bernal Institute, University of Limerick Ireland ning.Liu@ul.ie.
Huan ChenSchool of Physics and Information Technology, Shaanxi Normal University Xi'an China zlzhang@snnu.edu.cn.ORCID https://orcid.org/0000-0001-8372-9929
Tingting ZhangSchool of Physics and Information Technology, Shaanxi Normal University Xi'an China zlzhang@snnu.edu.cn.
Xiaohu MiSchool of Physics and Information Technology, Shaanxi Normal University Xi'an China zlzhang@snnu.edu.cn.
Zihe JiangSchool of Physics and Information Technology, Shaanxi Normal University Xi'an China zlzhang@snnu.edu.cn.
Ziming ZhouDepartment of Electrical and Electronic Engineering, Southern University of Science and Technology Shenzhen China.
Lei GuoSchool of Physics and Information Technology, Shaanxi Normal University Xi'an China zlzhang@snnu.edu.cn.
Min ZhangSchool of Physics and Information Technology, Shaanxi Normal University Xi'an China zlzhang@snnu.edu.cn.
Zhenglong ZhangSchool of Physics and Information Technology, Shaanxi Normal University Xi'an China zlzhang@snnu.edu.cn.ORCID https://orcid.org/0000-0003-1426-4042
Ning LiuDepartment of Physics and Bernal Institute, University of Limerick Ireland ning.Liu@ul.ie.
Hongxing XuSchool of Physics and Technology, Wuhan University Wuhan China hxxu@whu.edu.cn.ORCID https://orcid.org/0000-0002-1718-8834

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasmonic nanocavity is widely used for enhancing light-matter interaction. Here, an efficient plasmonic nanocavity of the cube-plate system is constructed for the fluorescence enhancement of rice-like CdSe/CdS nanorods (NRs) with tunable emission wavelength. Over ten thousand times fluorescence enhancement is achieved with the assistance of the plasmonic nanocavity. Additionally, a small splitting effect is observed in both photoluminescence and scattering spectra of the NRs in the nanocavity owing to the intermediate coupling effect between the NRs and plasmonic nanocavity, which provides a potential application for optical signal enhancement and strong light-matter interaction.

Identifiers

PMID36131769
PMCPMC9419206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.